AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 6,665.00
-41.00 (-0.61%)
Sep 24, 2026, 10:20 AM IST
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 167.73 billion as of September 23, 2026. Its market cap has decreased by -23.30% in one year.
Market Cap
167.73B
Enterprise Value
164.36B
Revenue
24.32B
Ranking
n/a
PE Ratio
98.89
Stock Price
6,665.00
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 167.73B, an increase of 11,467.59%. That is a compound annual growth rate of 21.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 167.73B | -25.54% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 355.11B |
| Piramal Pharma | 279.30B |
| Eris Lifesciences | 176.15B |
| Cohance Lifesciences | 173.21B |
| Alivus Life Sciences | 168.67B |
| Alembic Pharmaceuticals | 165.14B |
| NATCO Pharma | 145.98B |
| Sudeep Pharma | 135.21B |